{"title":"Interleukin-1α, tumor necrosis factor-α, and interleukin-12 secreted by zinc-induced murine macrophages in vivo and in vitro","authors":"M.D. Lastra, A.E. Aguilar, M.A. Cabañas, R. Hernandez, K. Humanez, R. Pastelin","doi":"10.1002/jtra.20003","DOIUrl":null,"url":null,"abstract":"Oral treatment of zinc modulates cytokine secretion during the gestation, lactation, and weaning periods. We used a experimental mice model of zinc supplementation during the perinatal stages to study the effects of this ion over the production of interleukin IL-1α, IL-12, and tumor necrosis factor-alpha by peritoneal macrophages. In addition, we determined the gene expression of these cytokines. Zinc (500 mg/L) was orally administered to mice from gestation to lactation (6-week treatment, Zn+) and weaning (9-week treatment). The serum cytokines IL-1α and IL-12 were assayed in the offspring at 21 and 42 days after birth. Our results showed a significant (P < 0.01) increase in cytokine production in the Zn+ animals at the end of the lactation stage. There was a tendency for the IL-1 concentration to decrease at postweaning; nevertheless, IL-12 concentrations were increased in mice at 42 days of age (P < 0.001). The production of IL-1α, IL-12, and tumor necrosis factor-alpha in the macrophages supernatants in vitro followed the same tendencies (P < 0.001). Molecular analysis showed an increase of mRNA synthesis in all cases, from 4-fold to 6-fold, in the cytokines analyzed. Our results suggest that the increase in the proinflammatory cytokines as a result of zinc administration may potentiate Th1 cells response, which could lead to the increase of cytokine production in deficient newborns. J. Trace Elem. Exp. Med. 17:123–135, 2004. © 2004 Wiley-Liss, Inc.","PeriodicalId":101243,"journal":{"name":"The Journal of Trace Elements in Experimental Medicine","volume":"17 2","pages":"123-135"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/jtra.20003","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Trace Elements in Experimental Medicine","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jtra.20003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
锌诱导小鼠巨噬细胞分泌的白细胞介素-1α、肿瘤坏死因子-α和白细胞介蛋白-12
锌的口服治疗可调节妊娠期、哺乳期和断奶期的细胞因子分泌。我们使用围产期补锌的实验小鼠模型来研究这种离子对腹膜巨噬细胞产生白细胞介素IL-1α、IL-12和肿瘤坏死因子α的影响。此外,我们还测定了这些细胞因子的基因表达。小鼠从妊娠期至哺乳期(6周治疗,Zn+)和断奶期(9周治疗)口服锌(500 mg/L)。在出生后21天和42天测定了后代的血清细胞因子IL-1α和IL-12。我们的结果显示,在哺乳期结束时,Zn+动物的细胞因子产生显著增加(P<;0.01)。断奶后IL-1浓度有下降的趋势;然而,在42天大的小鼠中,IL-12浓度增加(P<;0.001)。体外巨噬细胞上清液中IL-1α、IL-12和肿瘤坏死因子α的产生遵循相同的趋势(P<)。分子分析显示,在所有情况下,所分析的细胞因子中的mRNA合成都增加了,从4倍增加到6倍。我们的研究结果表明,锌给药后促炎细胞因子的增加可能会增强Th1细胞的反应,这可能导致缺陷新生儿细胞因子产生的增加。J.Trace Elem。Exp.Med.17:123–1352004。©2004 Wiley-Liss,股份有限公司。
本文章由计算机程序翻译,如有差异,请以英文原文为准。